These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36228896)

  • 21. Emerging mucus regulating drugs in inflammatory and allergic lung disease.
    Hauber HP; Zabel P
    Inflamm Allergy Drug Targets; 2008 Mar; 7(1):30-4. PubMed ID: 18473898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo models of mucin biosynthesis and function.
    Syed ZA; Zhang L; Ten Hagen KG
    Adv Drug Deliv Rev; 2022 May; 184():114182. PubMed ID: 35278522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients.
    Chace KV; Flux M; Sachdev GP
    Biochemistry; 1985 Dec; 24(25):7334-41. PubMed ID: 3002452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.
    Ramphal R; Houdret N; Koo L; Lamblin G; Roussel P
    Infect Immun; 1989 Oct; 57(10):3066-71. PubMed ID: 2777373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal goblet cells and mucins in health and disease: recent insights and progress.
    Kim YS; Ho SB
    Curr Gastroenterol Rep; 2010 Oct; 12(5):319-30. PubMed ID: 20703838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mucus and mucin--biochemical and medical problems].
    Gindzieński A; Zwierz K
    Postepy Biochem; 1991; 37(3-4):146-53. PubMed ID: 1812472
    [No Abstract]   [Full Text] [Related]  

  • 28. Biophysical characterization of mucin components HTM-1 and HTM-2 from tracheobronchial secretions of cystic fibrosis patients.
    Padhye NV; Shankar V; Reyes de la Rocha S; Sachdev GP
    Biochim Biophys Acta; 1994 Nov; 1209(1):56-60. PubMed ID: 7947982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus.
    Parmley RR; Gendler SJ
    J Clin Invest; 1998 Nov; 102(10):1798-806. PubMed ID: 9819365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.
    Thornton DJ; Sheehan JK; Lindgren H; Carlstedt I
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):667-75. PubMed ID: 2064605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current strategies for characterization of mucin-domain glycoproteins.
    Ince D; Lucas TM; Malaker SA
    Curr Opin Chem Biol; 2022 Aug; 69():102174. PubMed ID: 35752002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of mucus glycoproteins from cystic fibrotic sputum. Are there different families of mucins?
    Thornton DJ; Sheehan JK; Carlstedt I
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):677-82. PubMed ID: 2064606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucin networks: Dynamic structural assemblies controlling mucus function.
    Fass D; Thornton DJ
    Curr Opin Struct Biol; 2023 Apr; 79():102524. PubMed ID: 36753925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.
    Carnoy C; Ramphal R; Scharfman A; Lo-Guidice JM; Houdret N; Klein A; Galabert C; Lamblin G; Roussel P
    Am J Respir Cell Mol Biol; 1993 Sep; 9(3):323-34. PubMed ID: 8398170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucin Production and Hydration Responses to Mucopurulent Materials in Normal versus Cystic Fibrosis Airway Epithelia.
    Abdullah LH; Coakley R; Webster MJ; Zhu Y; Tarran R; Radicioni G; Kesimer M; Boucher RC; Davis CW; Ribeiro CMP
    Am J Respir Crit Care Med; 2018 Feb; 197(4):481-491. PubMed ID: 29099608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection.
    Wheeler KM; Cárcamo-Oyarce G; Turner BS; Dellos-Nolan S; Co JY; Lehoux S; Cummings RD; Wozniak DJ; Ribbeck K
    Nat Microbiol; 2019 Dec; 4(12):2146-2154. PubMed ID: 31611643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucin-type glycopeptide structure in solution: past, present, and future.
    Barchi JJ
    Biopolymers; 2013 Oct; 99(10):713-23. PubMed ID: 23765378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and quantification of mucin expression.
    Thomsson KA; Hansson GC
    Methods Mol Biol; 2011; 742():127-41. PubMed ID: 21547730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unified strategy for the synthesis of mucin cores 1-4 saccharides and the assembled multivalent glycopeptides.
    Pett C; Schorlemer M; Westerlind U
    Chemistry; 2013 Dec; 19(50):17001-10. PubMed ID: 24307362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical properties of purified human respiratory mucus glycoproteins: effects of sodium chloride concentration on the aggregation properties and shape.
    Chace KV; Naziruddin B; Desai VC; Flux M; Sachdev GP
    Exp Lung Res; 1989 Sep; 15(5):721-37. PubMed ID: 2806194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.